Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Exophthalmos
ADR ID BADD_A01560
ADR Hierarchy
05      Endocrine disorders
05.02      Thyroid gland disorders
05.02.02      Thyroid hyperfunction disorders
05.02.02.002      Exophthalmos
06      Eye disorders
06.09      Ocular structural change, deposit and degeneration NEC
06.09.04      Structural change, deposit and degeneration of eye NEC
06.09.04.001      Exophthalmos
Description Abnormal protrusion of both eyes; may be caused by endocrine gland malfunction, malignancy, injury, or paralysis of the extrinsic muscles of the eye. [MeSH]
MedDRA Code 10015683
MeSH ID D005094
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Bulging eyes | Constant exophthalmos | Exophthalmos | Exophthalmos NOS | Exophthalmos, unspecified | Intermittent exophthalmos | Other exophthalmic conditions | Proptosis | Pulsating exophthalmos | Proptoses
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00033Acetylsalicylic acid0.000033%
BADD_D00151Apixaban0.000043%
BADD_D00260Betamethasone--
BADD_D00284Bortezomib0.000224%
BADD_D00349Capecitabine0.000112%
BADD_D00364Carboplatin0.000112%
BADD_D00499Clomipramine--
BADD_D00500Clomipramine hydrochloride--
BADD_D00504Clopidogrel0.000032%
BADD_D00531Corticotropin--
BADD_D00532Cortisone--
BADD_D00533Cortisone acetate--
BADD_D00623Dexamethasone0.000145%
BADD_D00624Dexamethasone phosphate--
BADD_D00625Dexamethasone sodium phosphate--
BADD_D00775Enzalutamide0.000501%
BADD_D00861Exemestane0.001046%
BADD_D00917Fludrocortisone--
BADD_D00918Fludrocortisone acetate--
BADD_D00932Fluoxetine--
BADD_D01081Hydralazine--
BADD_D01086Hydrocortisone--
BADD_D01089Hydrocortisone cypionate--
BADD_D01091Hydrocortisone sodium succinate--
BADD_D01136Imatinib0.000336%
BADD_D01182Iopromide0.010670%
BADD_D01235Kinetin--
BADD_D01251Latanoprost0.000045%
BADD_D01285Levothyroxine0.000033%
BADD_D01303Lithium carbonate--
The 1th Page    1 2 3    Next   Last    Total 3 Pages